Suppr超能文献

非重症疾病患者恢复期血浆对 COVID-19 的 SARS-CoV-2 中和作用和血清学检测。

SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with nonsevere disease.

机构信息

Department of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA.

Division of Infectious Diseases and International Medicine, Department of Medicine, Center for Immunology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

出版信息

Transfusion. 2021 Jan;61(1):17-23. doi: 10.1111/trf.16101. Epub 2020 Oct 2.

Abstract

BACKGROUND

The transfer of passive immunity with convalescent plasma is a promising strategy for treatment and prevention of COVID-19, but donors with a history of nonsevere disease are serologically heterogenous. The relationship between SARS-Cov-2 antigen-binding activity and neutralization activity in this population of donors has not been defined.

STUDY DESIGN AND METHODS

Convalescent plasma units from 47 individuals with a history of nonsevere COVID-19 were assessed for antigen-binding activity of using three clinical diagnostic serology assays (Beckman, DiaSorin, and Roche) with different SARS-CoV-2 targets. These results were compared with functional neutralization activity using a fluorescent reporter strain of SARS-CoV-2 in a microwell assay.

RESULTS

Positive correlations of varying strength (Spearman r = 0.37-0.52) between antigen binding and viral neutralization were identified. Donors age 48 to 75 years had the highest neutralization activity. Units in the highest tertile of binding activity for each assay were enriched (75%-82%) for those with the highest levels of neutralization.

CONCLUSION

The strength of the relationship between antigen-binding activity and neutralization varies depending on the clinical assay used. Units in the highest tertile of binding activity for each assay are predominantly comprised of those with the greatest neutralization activity.

摘要

背景

使用恢复期血浆进行被动免疫转移是治疗和预防 COVID-19 的一种有前途的策略,但有非重症疾病史的供体在血清学上具有异质性。在这一供体人群中,SARS-CoV-2 抗原结合活性与中和活性之间的关系尚未确定。

研究设计和方法

评估了来自 47 名有非重症 COVID-19 病史的个体的恢复期血浆单位,使用三种具有不同 SARS-CoV-2 靶标的临床诊断血清学检测(贝克曼、DiaSorin 和罗氏)评估抗原结合活性。这些结果与使用 SARS-CoV-2 的荧光报告株在微孔板测定中的功能中和活性进行了比较。

结果

鉴定了抗原结合和病毒中和之间具有不同强度的正相关(Spearman r = 0.37-0.52)。48 至 75 岁的供体具有最高的中和活性。在每种检测中结合活性最高的三分位数的单位富集了具有最高中和水平的单位(75%-82%)。

结论

抗原结合活性与中和活性之间的关系强度取决于所用的临床检测。在每种检测中结合活性最高的三分位数的单位主要由具有最大中和活性的单位组成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验